Brewdog announces site target list and work on new brewery

Brewdog has announced its target locations for the next year, as work gets underway on the new brewery site.

The Scottish brewer and bar operator aims to include further sites in London and Manchester this year, as well as debut sites in Oxford, Cambridge and Norwich. It seeking freehold and leasehold sites, between 2,500 sq ft and 5,000 sq ft.

In terms of London properties, it is looking for areas near to Kings Cross, Peckham, Camberwell and Brixton, and also plans a bar close to its Ellon brewery in Inverurie.

The full list of target areas includes:

  • Stirling
  • Portsmouth
  • Exeter
  • Plymouth
  • Southend-on-Sea
  • Hull
  • Lincoln
  • Reading
  • Gloucester
  • Swansea
  • Worcester
  • Swindon
  • Canterbury
  • Bradford

It comes as the firm is expanding its brewing operation with the creation of an entirely new facility adjacent to the current 100HL brewhouse.

The first £3m of the hoped-for £25m crowdfunding scheme 'Equity for Punks IV' has been directly ploughed into the brewhouse project.

When completed in February 2016, the sitewill increase our capacity fivefold, housing a bespoke Ziemann 300HL brewhouse, which will operate in tandem with the existing facility.

As with the original brewhouse site, Brewdog will continually add tanks until it reaches the final plan - 40 new fermentation tanks. Alongside these, there will be five new malt silos, with a new Künzel 6-Roller Maltmill preparing all the grain needed for brewing.

The brewhouse will also be highly sustainable with an advanced heat recovery system, which sits alongside plans to further invest in green technologies across all of brewing sites.

Brewdog is also looking to install a C02 recovery system in the new brewery to enable zero carbon emissions.

The firm hope 130 new jobs will be created on the Ellon site in production and in the new three-storey offices, which it says may include 'a dog crèche, a Punk IPA Jacuzzi and a rooftop allotment so that we can become self-sufficient in marrows'.